Early studies suggest potential benefits in conditions involving impaired intestinal motility or altered gut hormone signaling, including metabolic disorders and certain gastrointestinal diseases
doi:10.1016/S0021-9673(00)95868-0 Tapkir AS, Biradar SM, Hajare SA, Chaudhari PD (2016) Development and validation of stability indicating assay methods (SIAMs) for citalopram hbr by using uv-visible spectrophotometer and rp-hplc
For a deeper primer on what peptides are and how they act, see what do peptides do, are peptides safe and are peptides steroids
The addition of the N-terminal tyrosine residue was incorporated to facilitate radiolabelling for pharmacokinetic research studies, and has since become a standard part of the compounds structure as used in laboratory research
doi:10.1126/science.1258366 Essuman K, Summers DW, Sasaki Y, Mao X, DiAntonio A, Milbrandt J
Growth hormone secretagogues, including sermorelin, require baseline IGF-1 measurement and oncology history screening before prescribing